Results
1 -
10 of
37IDO/TDO Inhibition in Cancer, Oncoimmunology Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2, Amino Acids Indoleamine 2,3-dioxygenase, Cancer Therapeutic Targets The role of indoleamine 2, 3 dioxygenase in regulating host immunity to leishmania infection, Journal of Biomedical Science The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma, Journal for ImmunoTherapy of Cancer Tryptophan Catabolism and Cancer Immunotherapy Targeting IDO Mediated Immune Suppression, Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy Immune Escape: Role of Indoleamine 2,3-Dioxygenase in Tumor Tolerance, Targeted Cancer Immune Therapy Clinical Trials Targeting the Kynurenine Pathway, Targeting the Broadly Pathogenic Kynurenine Pathway